AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 86 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $68,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVA Family Office, LLC | 1,173,200 | $1,865,000 | 1.14% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $1,387,000 | 0.82% |
| Cypress Capital Management LLC (WY) | 214,575 | $341,000 | 0.30% |
| Western Wealth Management, LLC | 982,350 | $1,562,000 | 0.23% |
| SRS Capital Advisors, Inc. | 615,659 | $979,000 | 0.14% |
| Willis Investment Counsel | 1,213,053 | $1,929,000 | 0.13% |
| Harvest Investment Services, LLC | 124,423 | $197,000 | 0.10% |
| Transform Wealth, LLC | 205,481 | $327,000 | 0.07% |
| COURIER CAPITAL LLC | 379,973 | $604,000 | 0.07% |
| BRIGHTON JONES LLC | 398,912 | $634,000 | 0.04% |